Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long‐term study

Abstract

Our study suggests that a significant rate of patients will recover from I¹³¹ therapy salivary side effects. As almost 30% of these remissions happened during our late stage follow-up, we highlight the necessity of a long-term follow-up in these patients.